| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |